Recombinant Vibrio vulnificus Sec-independent protein translocase protein TatA (tatA), partial

Shipped with Ice Packs
In Stock

Description

Table 1: V. vulnificus TAT System Components and Associated Genes

GeneFunctionRole in VirulenceReference
tatAChannel formationSecretion of toxins (e.g., RtxA)
tatBSubstrate recognitionIron acquisition, biofilm formation
tatCSignal peptide bindingRequired for full pathogenicity
  • Genetic context: The tatA gene in V. vulnificus is part of an operon with tatB and tatC, regulated by environmental signals such as iron availability .

  • Recombinant production: Partial TatA proteins are cloned using PCR amplification from genomic DNA, often fused with tags (e.g., Strep-tag II) for purification .

Table 2: Virulence Factors Secreted via the TAT System in V. vulnificus

SubstrateFunctionImpact on Host
RtxA toxinCytolysis, actin crosslinkingTissue damage, septicemia
MetalloproteasesDegradation of host proteinsImmune evasion
PhospholipasesCell membrane disruptionNecrosis, inflammation
  • Immune modulation: V. vulnificus RtxA, secreted via TAT, induces Th17 responses by activating dendritic cells, highlighting TatA’s indirect role in immune evasion .

  • In vivo expression: TatB (a homolog of TatA) is upregulated during infection, as identified through IVIAT (in vivo-induced antigen technology) .

Antibiotic Resistance Mechanisms

  • β-lactamase secretion: In Burkholderia pseudomallei and Mycobacterium tuberculosis, TatA facilitates the secretion of β-lactamases like PenA, reducing antibiotic efficacy .

  • Genetic studies: Deletion of tatA in P. aeruginosa increases susceptibility to carbapenems and cephalosporins, underscoring its role in resistance .

Research Applications of Recombinant TatA

  • Structural studies: Partial TatA proteins are used to resolve conformational dynamics via X-ray crystallography or cryo-EM .

  • Therapeutic targeting: Inhibitors of TatA could disrupt virulence and reverse antibiotic resistance, as demonstrated in P. aeruginosa chronic infection models .

Table 3: TatA Homologs in Bacterial Pathogens

OrganismTatA FunctionVirulence Link
Vibrio vulnificusToxin secretion, biofilm formationSepticemia, wound infections
Pseudomonas aeruginosaβ-lactamase secretionChronic lung infections
Burkholderia pseudomalleiHost cell invasionMelioidosis

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our default glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us for preferential development.
Synonyms
tatA; VV0180; Sec-independent protein translocase protein TatA
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Vibrio vulnificus (strain YJ016)
Target Names
tatA
Uniprot No.

Target Background

Function
Recombinant Vibrio vulnificus Sec-independent protein translocase protein TatA (tatA), partial. TatA is a component of the twin-arginine translocation (Tat) system, responsible for transporting large, folded proteins across membranes. These proteins contain a characteristic twin-arginine motif in their signal peptide. TatA is believed to form the protein-conducting channel of the Tat system.
Database Links

KEGG: vvy:VV0180

Protein Families
TatA/E family
Subcellular Location
Cell inner membrane; Single-pass membrane protein.

Q&A

What is the Tat secretion system and its significance in V. vulnificus pathogenicity?

The Twin-arginine translocation (Tat) pathway transports fully folded proteins across bacterial membranes, unlike the Sec pathway which transports unfolded proteins. In V. vulnificus, this system likely exports virulence factors that contribute to the bacterium's ability to cause acute inflammatory responses and septicemia in hosts. The significance of the Tat system must be considered within the context of V. vulnificus's complex virulence mechanisms, which include the well-studied MARTX toxins that undergo genetic recombination and contribute significantly to pathogenicity .

How does TatA function within bacterial secretion systems?

TatA functions as the channel-forming component of the Tat translocation machinery. It oligomerizes to form pores of variable diameter in the cytoplasmic membrane, allowing passage of folded proteins with twin-arginine signal peptides. In the context of V. vulnificus pathogenicity, TatA may facilitate export of proteins involved in the inflammatory response documented during infection, potentially contributing to the cytokine storm observed in fish models at 3 hours post-infection .

How might TatA expression vary across different V. vulnificus strains?

Based on observed genetic variability in V. vulnificus virulence factors, particularly the MARTX toxin which exists in four distinct variants (M-type, C-type, O-type, and D-type), we can hypothesize that TatA may also exhibit strain-specific variations . These variations could influence protein export efficiency and subsequently affect virulence. Research examining tatA gene sequences across clinical and environmental isolates would provide valuable insights into potential correlations with the lineage I and II classifications observed in V. vulnificus populations.

What is the relationship between TatA-dependent secretion and V. vulnificus virulence evolution?

Considering the ongoing genetic recombination observed in V. vulnificus rtxA1 genes, which has resulted in toxins with altered potency and novel arrangements of effector domains, similar evolutionary processes may affect the Tat system . Research should investigate whether tatA undergoes recombination with genes from other marine pathogens, similar to the recombination events documented with Vibrio anguillarum and plasmid-borne genes. This could reveal how the Tat secretion pathway contributes to the emergence of novel strains with altered virulence potential.

How might the TatA system contribute to the biphasic inflammatory response observed during V. vulnificus infection?

Transcriptomic studies have revealed that V. vulnificus triggers an atypical inflammatory response occurring in two phases: an early phase (3 hpi) characterized by upregulation of mucosal immune response genes and a late phase (12 hpi) marked by typical inflammatory cytokines and endothelial destruction . Research should explore whether TatA-dependent protein export contributes differentially to these phases, potentially by facilitating the secretion of specific virulence factors at different infection stages.

What role might TatA play in the environmental adaptation of V. vulnificus?

Given that V. vulnificus transitions between marine environments and host organisms, the Tat system may export proteins critical for environmental adaptation. The selection pressure for reduced virulence in environmental strains reported for MARTX toxins might similarly affect TatA-dependent secretion pathways . Comparative genomic analyses could reveal whether environmental versus clinical isolates exhibit differences in their Tat systems and substrate profiles.

What are the optimal strategies for expressing and purifying recombinant V. vulnificus TatA?

When working with membrane proteins like TatA, researchers should consider the following methodological approaches:

Expression SystemAdvantagesChallengesOptimization Strategies
E. coli BL21(DE3)High yield, well-establishedPotential toxicity, inclusion body formationLower induction temperature (16-20°C), use of solubility tags
Cell-free systemsAvoids toxicity issues, rapidLower yield, expensiveSupplement with lipids/detergents for membrane protein stability
Yeast expression systemsPost-translational modifications, less toxicitySlower growth, different codon usageCodon optimization, use of strong inducible promoters
Native V. vulnificus expressionAuthentic processing and foldingComplex growth requirements, lower yieldCulture under conditions mimicking infection environment

How can researchers effectively identify Tat substrates specific to V. vulnificus?

Identification of Tat substrates requires a multi-faceted approach combining:

  • Bioinformatic prediction of proteins containing twin-arginine signal motifs (S/T-R-R-x-F-L-K)

  • Comparative proteomics between wild-type and tatA knockout strains

  • Translocation assays using reporter fusions with potential Tat signal peptides

  • Analysis of secretome under conditions mimicking the early and late phases of infection identified in transcriptomic studies

What gene manipulation techniques are most effective for studying tatA function in V. vulnificus?

Based on successful genetic manipulations of V. vulnificus reported in the literature, researchers should consider:

  • Allelic exchange mutagenesis for creating clean tatA deletion mutants

  • Complementation with plasmid-expressed tatA to confirm phenotypes

  • Creation of tatA variants with specific mutations in functional domains

  • Reporter fusions to monitor tatA expression under different environmental conditions

  • CRISPR-Cas9 approaches for precise genome editing

How should researchers design in vivo experiments to assess TatA's role in V. vulnificus pathogenicity?

Experimental designs should incorporate the following elements:

Experimental ApproachKey ParametersExpected OutcomesData Analysis Considerations
Eel immersion infection model with tatA mutantsSurvival rates, bacterial loads in blood and tissuesReduced virulence if TatA exports key virulence factorsKaplan-Meier survival analysis, quantification of bacterial CFU in tissues
Transcriptomic analysis comparing host response to wild-type vs. tatA mutantsGene expression at 3 and 12 hpi in blood cellsAltered inflammatory response patternsDifferential expression analysis, pathway enrichment
Functional immune assays (proteolytic and hemolytic activity)Serum activity at different infection timepointsReduced tissue destruction with tatA mutantsEnzymatic activity assays, quantification of hemolysis
Cytokine profiling during infectionIL-17a/f1, IL-20, IL-1β levels in infected hostsAltered cytokine production patternsMultiplex cytokine assays, temporal analysis

This design builds on the established eel infection model that revealed the biphasic inflammatory response to V. vulnificus .

How can researchers effectively study TatA's role in V. vulnificus stress response and environmental adaptation?

Experimental approaches should include:

  • Growth assays under various stress conditions (oxidative stress, osmotic shock, temperature shifts) comparing wild-type and tatA mutants

  • Transcriptomic analysis of tatA expression under conditions mimicking environmental transitions

  • Identification of stress-related proteins dependent on the Tat system

  • Competition assays between wild-type and tatA mutants in mixed cultures under different environmental conditions

What in vitro systems can accurately model TatA function in V. vulnificus?

Researchers should consider:

  • Liposome reconstitution systems with purified TatA to study channel formation

  • Membrane vesicle transport assays using identified V. vulnificus Tat substrates

  • Structural studies (cryo-EM, X-ray crystallography) of TatA oligomers

  • Protein-protein interaction assays to identify TatA partners within the secretion machinery

How should researchers analyze transcriptomic data to understand TatA's role in V. vulnificus pathogenicity?

When analyzing transcriptomic data:

  • Compare gene expression patterns between wild-type and tatA mutants during infection, focusing on the early (3 hpi) and late (12 hpi) phases identified in previous research

  • Look for correlations between TatA-dependent secretion and the expression of inflammatory markers (IL-17a/f1, IL-20, IL-1β)

  • Analyze differential expression of genes related to hemolysis and proteolysis, which contribute to the hemorrhagic phenotype of V. vulnificus infection

  • Integrate findings with the proposed model of septicemia caused by V. vulnificus

What bioinformatic tools are most appropriate for predicting TatA structure and potential Tat substrates in V. vulnificus?

Recommended bioinformatic approaches include:

Analysis TypeRecommended ToolsKey ParametersValidation Methods
TatA structure predictionAlphaFold2, SWISS-MODELHomology with characterized TatA proteinsExperimental structure validation
Tat signal peptide predictionTatP, TatFind, PRED-TATTwin-arginine motif identificationIn vitro translocation assays
Comparative genomicsOrthoFinder, GET_HOMOLOGUESTatA conservation across Vibrio speciesFunctional complementation tests
Substrate function predictionInterPro, Pfam, GO enrichmentFunctional domain analysisSecretome analysis
Evolutionary analysisMEGA, MrBayesSelection pressure on tatAComparison with rtxA1 recombination patterns

How can researchers reconcile contradictory findings regarding TatA function in V. vulnificus?

When faced with contradictory results:

  • Consider strain-specific variations, as demonstrated for rtxA1 variants which show unexpected patterns of reduced toxicity in clinical isolates

  • Examine experimental conditions, particularly environmental factors that might influence Tat system activity

  • Look for evidence of compensatory mechanisms that might mask TatA phenotypes

  • Consider the biphasic nature of V. vulnificus infection when interpreting time-dependent results

  • Use multiple complementary approaches to validate key findings

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.